| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 01/03/2008 | CA2653384A1 Methods for the preparation of biologically active compounds in nanoparticulate form |
| 01/03/2008 | CA2648769A1 Urea derivatives of tropane, their preparation and their therapeutic application |
| 01/02/2008 | EP1873245A1 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 01/02/2008 | EP1873154A1 PYRAZOLO[1,5-a]PYRIDINE DERIVATIVE OR MEDICALLY ACCEPTABLE SALT THEREOF |
| 01/02/2008 | EP1873141A1 Calcium bis[2s)-3-[3-(2s)-3-(4-chloro-2-cyanophenoxy)-2- fluoropropoxy¨phenyl]-2-isopropoxypropionate] and intermediate thereof |
| 01/02/2008 | EP1872789A1 Pharmaceuticals kits comprising mesenchymals stem cells |
| 01/02/2008 | EP1872668A1 Nutrient composition |
| 01/02/2008 | EP1871416A2 Methods for treating osteoarthitis pain by administering a nerve growth factor antagonist and compositions containing the same |
| 01/02/2008 | EP1871392A1 Modulating angiogenesis with nod factors such as glucosamine oligosaccharides |
| 01/02/2008 | EP1537069B1 ANALOGUES OF LIPID MEDIATORS DERIVED FROM OMEGA-3 PUFAs AND METHODS OF USE |
| 01/02/2008 | EP1465614B1 A nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancer |
| 01/02/2008 | EP1435986B1 Igf-binding protein-derived peptide |
| 01/02/2008 | EP1416933B1 Substituted piperidines as modulators of the melanocortin receptor |
| 01/02/2008 | EP1268404B1 Malonamic acids and derivatives thereof as thyroid receptor ligands |
| 01/02/2008 | EP1254130B1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 01/02/2008 | EP1121116B1 Sustained release pharmaceutical composition of fluvastatin |
| 01/02/2008 | CN101098958A Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences |
| 01/02/2008 | CN101098706A Anti-inflammatory extract and agent and method for the production thereof |
| 01/02/2008 | CN101096337A Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 01/02/2008 | CN101095943A Compound recipe human body bone component extender |
| 01/02/2008 | CN101095941A Novel use of leuprorelin acetate in the preventing and treating of osteoporosis |
| 01/02/2008 | CN101095933A Chinese traditional medicine compound recipe for healing bones and treating wound |
| 01/02/2008 | CN101095929A Chinese traditional medicine ointment for treating hyperosteogeny and its method for making the same |
| 01/02/2008 | CN101095889A Plaster for treating ache and method for preparing the same |
| 01/02/2008 | CN101095884A Chinese patent drug powder medicine for treating various vertebral column diseases |
| 01/02/2008 | CN101095844A Chinese traditional medicine preparations for treating hyperosteogeny and method for preparing the same |
| 01/02/2008 | CN101095843A Pills for treating rheumatism and strengthening muscle |
| 01/02/2008 | CN101095786A Hyperplasia hernia ion rehabilitating ointment and method for preparing the same |
| 01/02/2008 | CN101095785A Chinese traditional medicine composition for treating arthritis hyperosteogeny intervertebral disc hernia ion |
| 01/02/2008 | CN101095783A Medicinal composition for treating spondyle disease and method for preparing the same |
| 01/02/2008 | CN101095730A Medicine for treating rheumatism atrophic arthritis |
| 01/02/2008 | CN101095729A Medicine for treating lumbar intervertebral disc protrusion |
| 01/02/2008 | CN101095719A Composition containing pagodatree flower, soybean and kudzu root extracts and method of making the same |
| 01/02/2008 | CN101095671A Iguratimod oral double-layer sustained-release preparation |
| 01/02/2008 | CN100359015C Human tumour-derived polyptde hormone phosphatonin |
| 01/02/2008 | CN100358920C Methods for identifying inducers and inhibitors of propteolytic antibodies, compositions and their uses |
| 01/02/2008 | CN100358919C Mammal prolactin variants |
| 01/02/2008 | CN100358892C 7-oxo pyridopyrimidines |
| 01/02/2008 | CN100358869C Carbamate caspase inhibitors and uses thereof |
| 01/02/2008 | CN100358595C Safety shield system for prefilled syringe |
| 01/02/2008 | CN100358577C Treatment of auto immune diseases with antagonists which bind to B cell surface markers |
| 01/02/2008 | CN100358556C Bone-recovering particles |
| 01/02/2008 | CN100358543C Combination of medication for treating osteoporosis and preparation method |
| 01/02/2008 | CN100358536C Prepn process and formula of compound chondroitin sulfate tablet |
| 01/02/2008 | CN100358498C Gentongping dripping pill for treating wind-cold channel blocking and its preparing method |
| 01/02/2008 | CN100358494C Inhalation system |
| 01/02/2008 | CN100358426C Method for preparing soymilk powder contg. micron ginseng, tortoise, pearl, pollen for tonifying-Yin, dispelling-fatigue and enriching calcium |
| 01/01/2008 | US7314940 For therapy and prophylaxis of neurodegenerative disorders related to apoptosis and/or inflammation |
| 01/01/2008 | US7314936 antiinflammatory agents; 1H-imidazo[4,5-b]pyridin-7-indole-2-yl- derivatives; autoimmune and proliferative disorders; inhibitors of cell adhesion molecule expression and inflammatory cytokine signal transduction; rheumatoid arthritis, ulcerative colitis/Crohn's disease, central nervous system diseases |
| 01/01/2008 | US7314934 Substituted 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds, e.g., 8-(2,6-Difluoro-phenyl)-4-(4-fluoro-2-methyl-phenyl)-2-(2-hydroxy-1-hydroxymethyl-ethylamino)-8H-pyrido[2,3-d]pyrimidin-7-one; CSBP/p38 kinase inhibitors |
| 01/01/2008 | US7314889 Compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
| 01/01/2008 | US7314888 2-{5-[(2,4-diisobutoxyphenyl)(hydroxy)methyl]-2-isobutoxyphenyl}-acetic acid; inhibits the activity of transcription factor AP-1 |
| 01/01/2008 | US7314881 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds |
| 01/01/2008 | US7314877 Benzofuran derivative |
| 01/01/2008 | US7314876 Administering to mammals nitrogen compounds, as mitogen activated kinase inhibitors, for prophylaxis asthma, respiratory system disorders, graft versus host disease, atherosclerosis and arthritis |
| 01/01/2008 | US7314873 (Halo-benzo carbonyl)heterobi cyclic p38 linase inhibiting agents |
| 01/01/2008 | US7314856 Adrenomedullin agonists |
| 01/01/2008 | US7314618 Novel nucleic acids encoding a fibroblast growth factor-23(FGF23) and proteins encoded thereby, mutations in which are associated with autosomal dominant rickets (ADHR). The invention further relates to methods of diagnosis of |
| 01/01/2008 | US7314617 Platelet rich plasma, no exogenous activator; sodium bicarbonate buffer, citrate dextrose anticoagulant |
| 12/27/2007 | WO2007149557A1 FUSED [d]PYRIDAZIN-7-ONES |
| 12/27/2007 | WO2007149031A1 Isoquinoline derivatives and their use as inhibitors of cytokine mediated diseases |
| 12/27/2007 | WO2007148837A1 Composition capable of promoting the production of collagen |
| 12/27/2007 | WO2007148835A1 Agent for overcoming resistance to anti-cancer agent |
| 12/27/2007 | WO2007148804A1 Composition capable of promoting the production of hyaluronic acid |
| 12/27/2007 | WO2007148803A1 Composition capable of promoting the production of hyaluronic acid |
| 12/27/2007 | WO2007148787A1 Process for production of a polymorph of 2-(3-cyano-4- isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid |
| 12/27/2007 | WO2007148711A1 N-(3,4-disubstituted phenyl)salicylamide derivative |
| 12/27/2007 | WO2007148697A1 Inhibitor of expression of nuclear transcription factor ap-1, and pharmaceutical product and product using the inhibitor |
| 12/27/2007 | WO2007148631A1 Composition for promoting the production of equol |
| 12/27/2007 | WO2007148307A1 Compositions and kits comprising a melatonin component and a chondroprotective component |
| 12/27/2007 | WO2006128142A8 Inhibitors of cytosolic phospholipase a2 |
| 12/27/2007 | WO2003066824A3 Albumin-fused kunitz domain peptides |
| 12/27/2007 | US20070299247 Heterodimeric human cytokine receptor comprising interleukin-10 or orphan receptor components for use in treatment of cell proliferative, inflammatory and immune disorders |
| 12/27/2007 | US20070299111 Benzamide derivatives and uses related thereto |
| 12/27/2007 | US20070299105 2-Cyanopropanoic Acid Amide and Ester Derivatives and Methods of Their Use |
| 12/27/2007 | US20070299104 Tetrahydropyranyl Cyclopentyl 1-Substituted and 1,1-Disubstituted Tetrahydroisoquinoline Modulators of Chemokine Receptor Activity |
| 12/27/2007 | US20070299092 Quinone Substituted Quinazoline and Quinoline Kinase Inhibitors |
| 12/27/2007 | US20070299090 Substituted 8-aminoalkoxy-xanthine compounds and compositions useful in the treatment of hyperlipidemia and diabetes |
| 12/27/2007 | US20070299075 e.g. 1-[4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methyl-pyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-4-(aminosulfonyl)aminobutan-2-ol; inhibit the tyrosine kinase activity of endothelial and fibroblast growth factors receptors; angiogenesis inhibitor; anticarcinogenic agent |
| 12/27/2007 | US20070299050 TNF alpha inhibitors; inflammatory diseases such as rheumatoid arthritis, Crohn's disease, septic shock syndrome and atherosclerosis |
| 12/27/2007 | US20070299029 Hepatic stellate cell specific promoter and uses thereof |
| 12/27/2007 | US20070299024 Cloning And Characterization Of 5'Flanking Regions Of A Human Aggrecanase-1 Gene |
| 12/27/2007 | US20070299009 Analogs of parathyroid hormone |
| 12/27/2007 | US20070299008 Transport Protein Which Is Used To Introduce Chemical Compounds Into Nerve Cells |
| 12/27/2007 | US20070298146 Bone metabolism improving agent |
| 12/27/2007 | US20070298124 ammonium trichloro(dioxyethylene-O,O')tellurate; epilepsy, inflammatory bowel disease, Crohn's disease and ulcerative colits |
| 12/27/2007 | US20070298123 Anti-angiogenic compositions and methods of use |
| 12/27/2007 | US20070298035 Recombinant immunoglobulin for targeting, treatment and prevention of cancer, transplant rejection and viral infection |
| 12/27/2007 | US20070297989 Novel anti-inflammatory androstane derivatives |
| 12/27/2007 | US20070297985 Method and composition for enhancing bone formation |
| 12/27/2007 | CA2656264A1 Method for producing crystal polymorphs of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid |
| 12/27/2007 | CA2656034A1 Fused [d]pyridazin-7-ones |
| 12/27/2007 | CA2655895A1 Agent for overcoming resistance to anti-cancer agent |
| 12/27/2007 | CA2655759A1 Compositions and kits comprising a melatonin component and a chondroprotective component |
| 12/26/2007 | EP1870467A1 Polypeptide hormone Phosphatonin |
| 12/26/2007 | EP1870465A2 Chemokine receptors 88-2B (CKR-3) and 88C and their antibodies |
| 12/26/2007 | EP1870409A1 Benzimidazole compound |
| 12/26/2007 | EP1870402A1 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors |
| 12/26/2007 | EP1870115A1 Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same |
| 12/26/2007 | EP1870105A1 Use of fucans in the treatment of psoriasis |